Table 3.
Diagnostic challenge Single definitive diagnosis Favored diagnosis SGT, undetermined |
191 (77%) 38 (15%) 19 (8%) |
---|---|
Benign Malignant Undetermined |
143 (58%) 91 (37%) 14 (6%) |
Pathology diagnosis Pleomorphic adenoma/myoepithelioma Mucoepidermoid carcinoma Polymorphous adenocarcinoma Cystadenoma Canalicular adenoma Adenoid cystic carcinoma Sialadenoma papilliferum Ductal papilloma Acinic cell carcinoma Clear cell carcinoma Adenocarcinoma, NOS Basal cell adenoma Secretory carcinoma Oncocytoma Epithelial-myoepithelial carcinoma Myoepithelial carcinoma Intraductal carcinoma Carcinosarcoma SGT, undetermined |
99 (39.9%) 42 (16.9%) 20 (8.1%) 16 (6.5%) 16 (6.5%) 9 (3.6%) 6 (2.4%) 3 (1.2%) 3 (1.2%) 3 (1.2%) 3 (1.2%) 2 (1.2%) 2 (0.8%) 1 (0.4%) 1 (0.4%) 1 (0.4%) 1 (0.4%) 1 (0.4%) 19 (7.7%) |
SGT: salivary gland tumor